Power Law company profile

Seres Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2010 · IPO 2015 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$105M

Market cap · Apr/2026

Revenue

$789K

Latest reported FY

Investors

3 investors on Seres Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Series B+ 1 investor entered at this stage

Global footprint

Web traffic by country

5.3K monthly visits
across markets

🇺🇸 United States69.8%

🏳️ Korea17%

🏳️ Republic of9.4%

🇮🇳 India1.9%

🇨🇦 Canada0%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo